esorubicin has been researched along with Head and Neck Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crivellari, D; Frustaci, S; Gasparini, G; Monfardini, S; Pacciarini, MA; Tirelli, U; Veronesi, A; Zagonel, V | 1 |
1 other study(ies) available for esorubicin and Head and Neck Neoplasms
| Article | Year |
|---|---|
Phase II study of esorubicin (4'-deoxydoxorubicin) in locally advanced or metastatic head and neck carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Doxorubicin; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis | 1987 |